Research Article: Clinical biomarkers for thyroid immune-related adverse events in patients with stage III and IV gastrointestinal tumors
Abstract:
Background: Thyroid immune-related adverse events (irAEs) associated with immune checkpoint inhibitor (ICI) treatment appear to correlate with a better prognosis. We aimed to investigate clinical biomarkers associated with thyroid irAEs.
No summary available.